Showing results (21-30 of 692) with videos related to
Sort By:
Pageof 70
Clinical Nuclear Medicine|December 23, 2016
FDG PET/CT in Malignant Eccrine SpiradenomaGabriela Sanchez Petitto, Nawid M Sarwari, Preetesh Jain, et al.Blood Cancer Journal|February 16, 2023
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutationsYuxuan Che, Yang Liu, Yixin Yao, et al.Human Pathology|March 9, 2024
TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are presentDo Hwan Kim, Saima Siddiqui, Preetesh Jain, et al.Human Pathology|October 16, 2021
Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 casesMehrnoosh Tashakori, Do Hwan Kim, Rashmi Kanagal-Shamanna, et al.Leukemia & Lymphoma|May 10, 2021
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphomaRavi K Goyal, Preetesh Jain, Saurabh P Nagar, et al.Journal for Immunotherapy of Cancer|October 17, 2020
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2Michael Wang, Preetesh Jain, T Linda Chi, et al.Leukemia Research|June 10, 2017
Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcomePreetesh Jain, Sa Wang, Keyur P Patel, et al.Blood Advances|June 30, 2020
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysisHolly A Hill, Xinyue Qi, Preetesh Jain, et al.NPJ Precision Oncology|November 21, 2025
Integrative profiling strategies to guide personalized therapy in mantle cell lymphoma: a pilot studyYang Liu, Holly A Hill, Yijing Li, et al.Cancer Research Communications|August 4, 2023
Integrative Prognostic Machine Learning Models in Mantle Cell LymphomaHolly A Hill, Preetesh Jain, Chi Young Ok, et al.Pageof 70